These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26814245)

  • 1. Off-Label, Low-Dose Naltrexone for Refractory Painful Diabetic Neuropathy.
    Hota D; Srinivasan A; Dutta P; Bhansali A; Chakrabarti A
    Pain Med; 2016 Apr; 17(4):790-1. PubMed ID: 26814245
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of diabetic neuropathy with pentoxifylline: case report.
    Kalmansohn RB; Kalmansohn RW; Markham CH; Schiff DL
    Angiology; 1988 Apr; 39(4):371-4. PubMed ID: 3364803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline personality, opioids, and naltrexone.
    Saper JR
    Headache; 2000 Oct; 40(9):765. PubMed ID: 11091301
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetic peripheral neuropathic pain: case studies.
    Belgrade MJ; Cole BE; McCarberg BH; McLean MJ
    Mayo Clin Proc; 2006 Apr; 81(4 Suppl):S26-32. PubMed ID: 16608050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients.
    Sturn KM; Collin M
    Int J Pharm Compd; 2016; 20(3):197-201. PubMed ID: 28333660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis.
    Roginsky G; Alexoff A; Ehrenpreis ED
    J Clin Gastroenterol; 2015 Oct; 49(9):794-5. PubMed ID: 26280708
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium valproate in painful diabetic polyneuropathy.
    Sindrup SH; Otto M; Bach FW; Jensen TS
    Acta Neurol Scand; 2003 Dec; 108(6):443-4. PubMed ID: 14616298
    [No Abstract]   [Full Text] [Related]  

  • 9. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial.
    Stacey BR; Dworkin RH; Murphy K; Sharma U; Emir B; Griesing T
    Pain Med; 2008 Nov; 9(8):1202-8. PubMed ID: 18346060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing acupuncture by low dose naltrexone.
    Hesselink JM; Kopsky DJ
    Acupunct Med; 2011 Jun; 29(2):127-30. PubMed ID: 21415049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option?
    Ramanathan S; Panksepp J; Johnson B
    Psychosomatics; 2012; 53(6):591-4. PubMed ID: 22480625
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study.
    Lubin G; Weizman A; Shmushkevitz M; Valevski A
    Hum Psychopharmacol; 2002 Jun; 17(4):181-5. PubMed ID: 12404685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to maximize the efficacy of naltrexone for alcohol dependence.
    O'Malley SS
    NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.
    Younger J; Noor N; McCue R; Mackey S
    Arthritis Rheum; 2013 Feb; 65(2):529-38. PubMed ID: 23359310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of naltrexone for alcoholism in a liver transplant recipient: side effects and safety.
    Weinrieb RM; O'Brien CP
    Am J Addict; 2004; 13(5):495-7. PubMed ID: 15764427
    [No Abstract]   [Full Text] [Related]  

  • 16. How is naltrexone used in the treatment of alcoholism?
    Osser DN
    Harv Ment Health Lett; 1998 Dec; 15(6):8. PubMed ID: 9833574
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of obsessive-compulsive cutting behavior with naltrexone.
    Bystritsky A; Strausser BP
    J Clin Psychiatry; 1996 Sep; 57(9):423-4. PubMed ID: 9746454
    [No Abstract]   [Full Text] [Related]  

  • 18. An open-label pilot study of naltrexone in childhood-onset trichotillomania.
    De Sousa A
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):30-3. PubMed ID: 18294086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone in the treatment of pathological gambling and alcohol dependence.
    Crockford DN; el-Guebaly N
    Can J Psychiatry; 1998 Feb; 43(1):86. PubMed ID: 9494755
    [No Abstract]   [Full Text] [Related]  

  • 20. Naltrexone for alcohol dependence.
    Sinclair JD; Alho H; Shinderman M
    N Engl J Med; 2002 Apr; 346(17):1329-31; author reply 1329-31. PubMed ID: 11973854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.